澳门巴黎人娱乐

transition
silde-l

International technology group integrating R & D, production and sales.

  • Chemical production base
  • Biochemical drug production base
  • TCM production base

Chemical production base

chemistry-1

Suzhou No. 1 Pharmaceutical Co., Ltd. traced its origin to the Fukang pharmacy, which was founded in 1923. It has a history of nearly one hundred years, and it is the production base of chemical medicine group. In 2013, Suyi was certified by the 2010 edition of the State Administration of food and Drug Administration (CFDA), and was awarded the title of "high-tech enterprise" in Jiangsu Province in 2013. It is one of the best, best managed and oldest manufacturing enterprises in China at present. The factory is located in China Singapore Suzhou Industrial Park, covering an area of 100 thousand square meters, of which about 40 thousand square meters of land is available for future expansion of production capacity.

Su Yi has 129 products registration number, 33 products for the national basic drug list of products, a total of freeze-dried powder, powder, solid preparations (including antitumor drugs) and urine test paper, and other five production workshops, equipped with professional QC laboratory and comprehensive warehouse; production energy: freeze dry powder 50 million / year, powder needle The dosage is 50 million Sticks / year, the solid preparation is 1 billion tablets / year, the anti-tumor tablet 250 million tablets / year, the urine test paper is 100 million pieces / year. At present, nearly 20 kinds of products are being produced and sold in the factory. "Shu Si" (Quetiapine Fumarate Tablets), the core product, is a famous brand and high tech product in Jiangsu province. It is the main drug in the field of disease treatment in the central nervous system. Another product Zhuo Ao (Ambroxol Hydrochloride for Injection) is the main drug used in the treatment of respiratory diseases.

Biochemical drug production base

biology-1

NT biopharmaceutical Jiangsu Co., Ltd. was founded in 2014. It is a high-tech biopharmaceutical enterprise and a group of bio chemical drug production base. In the future, the core of the new national anti-cancer drug "Xi dike" (uric acid peptide injection) will be built into a production base for the group of cancer and blood system diseases. The factory is designed and built according to the new version of GMP standard. It is an innovative production enterprise with advanced equipment and management standard at present.

NT biopharmaceutical Jiangsu Co., Ltd. has 1095 square meters of polyuric acid peptide raw material workshop, 1486 square meter preparation workshop, 2069 square meter warehouse and 1700 square meter automatic temperature control and cold storage, among which "urate peptide injection" production line is designed to produce 1 million bottles.

The factory is located in Taizhou China Pharmaceutical City, covering an area of 65932 square meters, with a total construction area of about 66 thousand square meters.

TCM production base

tcm-1

NT pharmaceutical Changsha Pharmaceutical Co., Ltd. is a group traditional Chinese medicine production base. It mainly focuses on product development and production in the field of liver disease treatment. The future will be a new "Songzi pill" as the core, to build a group of liver disease drug production base. The factory was granted the production license issued by the State Food and Drug Administration (CFDA) in 2012 and approved by the new version of GMP (2010 Edition).

Located in Changsha national biological industry base in Hunan, the factory area covers an area of about 26000 square meters. It has modern traditional Chinese medicine extraction technology and equipped with GMP standard production facilities. The production capacity is 40000000 bottles of pills, 300000000 tablets of traditional Chinese medicine, 100000000 capsules and 20000000 granules. The "Songzi pill", the annual production capacity of 2 million boxes.